Meridian Bioscience Stock Price and Value Analysis

Should you buy Meridian Bioscience stock? (NasdaqGS:VIVO). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is making money at a decent rate.
  • This company has stable growth.
  • This company has a large dividend yield!
  • This stock looks overpriced.

Inside the VIVO Numbers

VIVO Price
(Meridian Bioscience stock price per share)
[?] VIVO Fair Price
(based on intrinsic value)
[?] VIVO Safety Price (based on a variable margin of safety) $8.63
[?] PE Ratio versus Sector 35% higher than other Healthcare stocks
[?] PE Ratio versus Industry 84% lower than other Diagnostic Substances stocks
[?] Cash Yield 4.72%
[?] Free Cash Flow Jitter 19%
[?] Dividend Yield 3%

Is Meridian Bioscience Stock on Sale?

We believe that Meridian Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Meridian Bioscience looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy VIVO Stock?

Does Meridian Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.